Laparoscopic Sacrocolpexy Versus Lateral Suspension
SUSPENSION
2 other identifiers
interventional
7
1 country
1
Brief Summary
Surgical treatment of genital prolapse can be performed by laparoscopic surgery or by vaginal surgery, with or without using meshes. Laparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall and the promontory is the gold standard procedure to treat anterior prolapse or of the vaginal vault. Most of studies shows a success rate of 80% of this procedure. However, access to the promontory could be difficult in patients because of adherences or anatomical reasons. This step of the procedure also exposes to risk of ureteral or vascular injuries. Recent issues have also found spondylodiscitis cases. The technique of laparoscopic lateral suspension with mesh was developed by Dubuisson in 1998 allows not to have to approach the promontory and avoids both the risk of vascular injury and ureteral damage of laparoscopic sacrocolpopexy. Instead of attach the mesh to the promontory, the procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall. The aim of this study is to compare the clinical and functional efficiency of the lateral suspension versus laparoscopic sacrocolpopexy. It is a prospective, randomized, monocentric study compared two groups The study hypothesis is that the lateral suspension would provide correction than the laparoscopic sacrocolpopexy. The primary outcome is the comparison of anatomic correction rates at 1 year Success is defined as 1 year Ba et C points \< -1 centimeter in POP-Q international score. Secondary endpoints are improve of quality of life evaluated with the validated P-QOL questionnaire, and complications rates, including post-operative posterior prolapse. Number of subjects required is 72 patients, 36 in each group having a laparoscopic sacrocolpopexy or lateral suspension. Outcomes will be evaluated at 1 month and 1 year post-operative consultation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2018
CompletedFirst Submitted
Initial submission to the registry
May 22, 2018
CompletedFirst Posted
Study publicly available on registry
July 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2021
CompletedAugust 9, 2022
August 1, 2022
3 years
May 22, 2018
August 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate cervico-urethral hypermobility
Success is defined by two points inferior at 1 centimeter in Pelvic organs prolapse quantification (POP-Q) international score. defining a symptomatic or asymptomatic state
one year
Study Arms (2)
promontory
ACTIVE COMPARATORLaparoscopic sacrocolpopexy, which consist in fixing a mesh between vaginal anterior wall
laparoscopic lateral suspension
ACTIVE COMPARATORThe procedure consists in spreading out bilaterally, a subperitoneal T-shaped mesh in the anterior abdominal wall
Interventions
Laparoscopy performed according to the usual technique of the participating center with pneumoperitoneum between 12 and 15 mmHg. Placement of the 5 mm trocar operator left and right iliac fossa and 5 mm pubic addition.
Eligibility Criteria
You may qualify if:
- Patients at least 18 years old.
- Patients who agreed to participate in the study and signed informed consent.
- Patient affiliated to a social protection system.
- Surgical indication by laparoscopy of prolapse cure symptomatic of the anterior stage and / or isolated medium.
You may not qualify if:
- Minor patient.
- Patient refusing to sign the consent or unable to receive the necessary information to give informed consent.
- Patient not affiliated to a social protection system.
- Presence of one or more contraindication (s) to laparoscopy
- Presence of posterior prolapse requiring surgical treatment
- Need for an associated surgical procedure.
- Major people under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux de Marseille
Marseille, 13354, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2018
First Posted
July 11, 2018
Study Start
April 11, 2018
Primary Completion
April 20, 2021
Study Completion
April 20, 2021
Last Updated
August 9, 2022
Record last verified: 2022-08